GlassScriptPhysician profile
Charles E Pugar
NPI 1932350626
$18,936.47
in general payments reported to CMS, 2019-2025
31 companies · $8,493 in 2025
The $8,493 reported for 2025 was more than what 89% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,161 · 2020: $1,414 · 2021: $2,810 · 2022: $1,381 · 2023: $1,212 · 2024: $1,466 · 2025: $8,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,938 · Travel and Lodging: $3,432 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,938.44 |
| Travel and Lodging | $3,431.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,444.76 | 2021-2025 | Endurant Iis, Na, In.Pact Admiral |
| W. L. Gore & Associates, INC. | $4,063.61 | 2021-2025 | Product In Development, Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Silk Road Medical, INC. | $1,281.31 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Endologix LLC | $1,114.76 | 2019-2025 | Endocross Device, Torus Stent Graft System |
| Bard Peripheral Vascular, INC. | $1,071.36 | 2019-2021 | |
| Medtronic Vascular, INC. | $864.83 | 2019-2020 | |
| Cook Medical LLC | $505.88 | 2020-2025 | Cook, Zenith, Zenith Spiral-Z |
| Organogenesis INC. | $466.31 | 2021-2025 | Apligraf |
| Smith+Nephew, INC. | $399.51 | 2019-2025 | Grafix Pl, Stravix Pl, Renasys Touch |
| Inari Medical, INC. | $219.56 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kerecis Limited | $182.86 | 2020-2022 | |
| Tactile Systems Technology INC | $172.24 | 2019-2021 | |
| Reflow Medical INC | $157.21 | 2025 | |
| Contego Medical, INC | $153.12 | 2024-2025 | |
| Shockwave Medical, INC | $114.29 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $110.20 | 2019-2025 | Ranger, Eluvia |
| Cardiovascular Systems INC. | $92.48 | 2019-2023 | Diamondback Peripheral |
| Philips North America LLC | $84.57 | 2020-2025 | Intrasight Mobile |
| Angiodynamics, INC. | $77.50 | 2023-2024 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $73.80 | 2021 | |
| Davol INC. | $62.31 | 2021 | |
| Stryker Corporation | $51.21 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Becton, Dickinson and Company | $31.97 | 2024 | Rotarexs 6 F X 135 Cm |
| Thrombolex, INC. | $26.58 | 2025 | Bashir Endovascular Catheter |
| Avinger INC. | $24.44 | 2022 | |
| Cagent Vascular INC | $18.58 | 2022 | |
| Lundbeck LLC | $17.92 | 2023 | Vyepti |
| Cardinal Health 200 LLC | $15.07 | 2019 | |
| Avenu Medical INC. | $13.37 | 2020 | |
| Kci USA, INC. | $13.33 | 2019 | |
| Lemaitre Vascular, INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Pugar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.